| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Design Therapeutics, Inc. | Chief Medical Officer | Common Stock | 4,756 | $11,162 | $2.35 | 13 Mar 2024 | Direct |
| Septerna, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 125,000 | 06 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SEPN | Septerna, Inc. | 06 Feb 2026 | 1 | $0 | 4 | Chief Medical Officer | 10 Feb 2026, 19:08 |
| SEPN | Septerna, Inc. | 07 Aug 2025 | 1 | $0 | 4 | Chief Medical Officer | 11 Aug 2025, 19:08 |
| SEPN | Septerna, Inc. | 24 Oct 2024 | 0 | $0 | 3 | Chief Medical Officer | 24 Oct 2024, 21:37 |
| DSGN | Design Therapeutics, Inc. | 13 Mar 2024 | 0 | $0 | 3 | Chief Medical Officer | 20 Mar 2024, 19:57 |